(19)
(11) EP 1 175 223 A2

(12)

(88) Date of publication A3:
10.05.2001

(43) Date of publication:
30.01.2002 Bulletin 2002/05

(21) Application number: 00923454.3

(22) Date of filing: 17.04.2000
(51) International Patent Classification (IPC)7A61K 38/17, A61K 48/00, C07K 14/47, C12N 5/10, C12N 15/12, G01N 33/50, A61P 37/02
(86) International application number:
PCT/US0010/340
(87) International publication number:
WO 0063/241 (26.10.2000 Gazette 2000/43)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.04.1999 US 129772 P

(71) Applicants:
  • CHILDREN'S MEDICAL CENTER CORPORATION
    Boston Massachusetts 02115 (US)
  • DANA-FARBER CANCER INSTITUTE, INC.
    Boston, MA 02115 (US)

(72) Inventors:
  • ASHKAR, Samy
    Boston, MA 02115 (US)
  • WEBER, Georg
    Chestnut Hill, MA 02647 (US)
  • GLIMCHER, Melvyn
    Boston, MA 02130 (US)
  • CANTOR, Harvey
    Wellesley, MA 02481 (US)

(74) Representative: Holdcroft, James Gerald, Dr. et al
Graham Watt & Co., Riverhead
Sevenoaks, Kent TN13 2BN
Sevenoaks, Kent TN13 2BN (GB)

   


(54) METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE